Newsroom

SKANDERBORG, Danimarca--(BUSINESS WIRE)--Lampada per unghie a UV Gelpolish Codice a barre: 5744002100249 N. modello: 29 Il nostro fornitore dell'articolo ”Lampada per unghie UV Gelpolish Factory”, The Room Aps, ha riscontrato un importante difetto nel dispositivo di connessione BQ-36, che ne compromette la sicurezza. Si raccomanda ai consumatori di sospendere immediatamente l'uso di questo prodotto. Il prodotto viene venduto nei punti vendita NORMAL. I consumatori possono restituire il prodotto...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (siège : Chuo-ku, Tokyo ; président-directeur général : Toshiaki Nagasato) a annoncé aujourd’hui avoir conclu un accord de partenariat avec MBC BioLabs, une organisation privée qui soutient le développement de startups biotechnologiques dans la région de la baie de San Francisco, en Californie. MBC BioLabs fournit des installations de recherche entièrement équipées et une communauté solidaire qui aide les entrepreneurs biotechnologiques à pas...

TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Hauptsitz: Chuo-ku, Tokio; President & CEO: Toshiaki Nagasato) gab heute bekannt, dass eine Partnerschaftsvereinbarung mit MBC BioLabs unterzeichnet wurde, einer Privatfirma, die die Entwicklung von biotechnischen Startup-Unternehmen in der Umgebung der San Francisco Bay im US-Bundesstaat Kalifornien unterstützt. MBC BioLabs stellt vollumfänglich ausgestattete Forschungsanlagen und eine unterstützende Gemeinschaft bereit, die biotechnisc...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 18.12.2025 MDEC.LN IE0007FIJUO5 2.00 USD 40.00 20.000  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Growth Strength UCITS ETF 18.12.2025 FTEG.LN IE0009F7UB30 50,002.00 EUR 1,006,044.59 20.120  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 18.12.2025 MSEP.LN IE0009DRFET8 150,002.00 USD 4,033,894.84 26.892  ...

NEW YORK--(BUSINESS WIRE)--Led by Venrock, round follows FINNY’s $4.3 million seed raise in 2024 and will fuel the platform’s meteoric growth since launch...

EDINBURGH, Scotland--(BUSINESS WIRE)--Wearables technology firm StretchSense, which specialises in high-tech data capture gloves, has secured its latest external investment, a $2.3 million (£1.75m) round led by PXN Ventures and supported by Scottish Enterprise, as the company aims to drive the global expansion of its extended reality (XR) training glove that enables organisations to immerse staff in simulated environments. To date, StretchSense has raised almost $20 million through three extern...